Epilepsy

Version: 2.1
Published: 15 February 2016
Condition for which Ig use is in exceptional circumstances only

This medical condition has either been superseded or has become inactive
View Current Version  Print
Specific Conditions
  • Epilepsy (rare childhood cases)
Level of Evidence Evidence of probable benefit – more research needed (Category 2a)
  • Landau–Kleffner syndrome
  • Lennox–Gastaut syndrome
Intravenous immunoglobulin (IVIg) should be considered in childhood cases only after failure of all conventional therapies and full assessment by a Paediatric Neurologist.

Refer to the current product information sheet for further information.

The aim should be to use the lowest dose possible that achieves the appropriate clinical outcome for each patient.